Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.
about
The Role of PPARs in CancerProstacyclin-dependent apoptosis mediated by PPAR deltaProstacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cellsThe role of peroxisome proliferator-activated receptors in carcinogenesis and chemopreventionRegulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healingExpression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphologyGenomic approaches to research in pulmonary hypertensionEicosanoid pathway in colorectal cancer: Recent updatesEicosanoid storm in infection and inflammationLung cancer chemoprevention: current status and future prospectsThe diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancerTherapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.COX-2 and cancer: a new approach to an old problemInflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequencesSite-specific molecular design and its relevance to pharmacogenomics and chemical biology.Transcriptional and Non-Transcriptional Functions of PPARβ/δ in Non-Small Cell Lung Cancer.PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine.PPARdelta status and mismatch repair mediated neoplasia in the mouse intestine.A voting approach to identify a small number of highly predictive genes using multiple classifiers.Curcumin suppresses PPARdelta expression and related genes in HT-29 cellsDose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxibRole of Peroxisome Proliferator-Activated Receptor (PPAR)δ in Embryonic Stem Cell Proliferation.Peroxisome Proliferator-Activated Receptors Protect against Apoptosis via 14-3-3.Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22.Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation.Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase.A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells.Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activityNuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicitiesHeightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma.Effect of α-tocopheryl succinate on the molecular damage induced by indomethacin in C6 glioma cellsIs peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?Variants of the PPARD gene and their clinicopathological significance in colorectal cancer.Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.The role of COX-2 in intestinal inflammation and colorectal cancerCrosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progressionIntegrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.
P2860
Q21342955-17D504C0-3C4D-4F7B-BE87-ACC24386E390Q24291677-1FA671BB-19B2-480C-B73D-7C4D362B4EF1Q24303556-E73DD9C2-3F41-4D67-BFC8-27E09F0ECBF6Q24314509-0399C980-7E5B-464C-86E1-50CCDE0119F0Q24601222-EF16B373-FB98-42DF-A6ED-4EE61A9539EEQ24643750-513E8C37-7128-466A-862D-D49009C7B95DQ24652863-70E86FD8-C6E7-4D91-AAFC-732058EFBEB2Q24792044-80436953-1698-49F7-8EF0-29A9EA57081FQ26778011-CBF8E643-FFDE-465C-98D5-B5D997401C56Q26851985-4648CE49-A1C7-4597-9299-DB0F230D55A3Q26995495-D1F65961-2003-43DE-A312-D44051895E38Q26997789-95D0308C-6DF5-4537-A22E-AFE8EF26F5F8Q27687166-572B170E-DDA4-4CE5-BF70-79580F9DE8CEQ28191533-48274CDB-8384-41D0-B34B-F01AAA0470E1Q28193430-627EB097-F432-422E-8984-31F30A11D20CQ30330026-8461CC49-7402-41F7-946A-84EA449D208BQ31103456-6E74790C-45B5-499B-9536-6D2CB33B6F31Q33207854-1055E763-C24A-4FE8-A97D-1767B548360AQ33242095-FACA1C1E-649F-4B54-BA5A-BB976974CF11Q33407768-63D62078-A359-406A-A561-1C08D4A39481Q33419214-BA74F761-9FA0-48EB-BDFC-F30B7E580A69Q33613090-0F4E37C7-F423-434A-92DF-DE991D09C374Q33614818-1697165E-DA6A-4079-8684-6E54FD8BA0DFQ34123741-31E77169-4AF0-4932-B250-8DC47A1B5824Q34162969-E046E18F-50DF-44EB-ADA6-8AA9C671DA69Q34164353-E1815172-95D1-4D03-BF31-86DFE0DDBCC6Q34210726-7E3A4100-298D-443C-A78E-45B523748F02Q34262817-A50B35C8-18B5-48C7-A9CE-0FB7D20BA986Q34478047-700B7546-74C4-425E-8630-A9B51F456103Q34524549-E5EEA88A-8C2C-4CB5-AA86-EADFFAE5B388Q34565656-DBE26B49-7BD0-462D-928D-553551571289Q34625038-256C3263-6BB4-4589-A918-293F430F260CQ34786102-93751B87-AB90-4014-99BF-544463CCDCADQ34795572-9FCB672B-948A-43FA-AD4D-4D63EDCD048FQ34897476-74521423-D78F-47BC-8E3D-9ECA98C97C07Q35082686-D1FF7255-F10D-432E-8C39-7248D059DC77Q35173520-B036C7C6-CBE5-45CE-A5FA-3B2D0AA04302Q35234704-677B500D-A5C3-4067-91D8-F48B182E812AQ35539784-F9F388B8-5D31-468E-9AA8-1326C1E081FFQ35569436-0C8E30CD-E405-457A-BCD0-958137CD7F4F
P2860
Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Prostacyclin-mediated activati ...... or delta in colorectal cancer.
@en
Prostacyclin-mediated activati ...... or delta in colorectal cancer.
@nl
type
label
Prostacyclin-mediated activati ...... or delta in colorectal cancer.
@en
Prostacyclin-mediated activati ...... or delta in colorectal cancer.
@nl
prefLabel
Prostacyclin-mediated activati ...... or delta in colorectal cancer.
@en
Prostacyclin-mediated activati ...... or delta in colorectal cancer.
@nl
P2093
P2860
P356
P1476
Prostacyclin-mediated activati ...... or delta in colorectal cancer.
@en
P2093
M W Geraci
R N DuBois
T M Willson
W F Krause
P2860
P304
13275-13280
P356
10.1073/PNAS.97.24.13275
P407
P577
2000-11-01T00:00:00Z